Meet the Team

We have a highly talented team who are passionate about researching and developing systematic trading strategies and infrastructure.

Meet the Team

We have a highly talented team who are passionate about researching and developing systematic trading strategies and infrastructure.

  • DR EWAN KIRK

    DR EWAN KIRK

    Chief Investment Officer and founder of Cantab

    Dr Ewan Kirk is Chief Investment Officer of Cantab. He co-founded Cantab Capital Partners in 2006, which became part of GAM Systematic in October 2016. His daily focus is research and development, risk management and managing the Cantab quantitative team. Prior to founding Cantab, Ewan Kirk ran the 120-strong Goldman Sachs Strategies Group in Europe, where he was responsible for all of Goldman Sachs’ quantitative technology. Ewan Kirk holds a PhD in Mathematics (General Relativity) from the University of Southampton, a Certificate in Advanced Study in Applied Mathematics from the University of Cambridge and achieved a First Class degree in Natural Philosophy and Astronomy at the University of Glasgow.
  • DR MATTHEW KILLEYA

    DR MATTHEW KILLEYA

    Co-Chief Investment Officer

    Dr Matthew Killeya is Co-Chief Investment Officer at Cantab Capital Partners, which became part of GAM Systematic in October 2016. His primary focus is on strategy development and he has driven ideas in all areas of the portfolio. His current interests include the application of Bayesian analysis to the investment problem, the use of information from options markets for strategy signalling, and short term prediction and optimisation for execution algorithms. Matt Killeya has spent over ten years in the industry implementing and managing systematic strategy research and was previously a senior managing researcher at Winton Capital Management. Matt Killeya holds a PhD in Bayesian statistics and a first class Master of Mathematics degree from Durham University.
  • ADAM GLINSMAN

    ADAM GLINSMAN

    Co-Head of GAM Systematic

    Adam Glinsman is Co-Head of GAM Systematic and focuses on the management and evolution of all non-investment aspects of the business. He was CEO of Cantab Capital Partners, which became part of GAM Systematic in October 2016. Before joining Cantab, Adam Glinsman was COO and a Partner of Lansdowne Partners between 2003 and 2009. He is a founder board member of Cambridge Innovation Capital, a leading institutional investor in high-growth, innovative technology companies commercialising IP across the Cambridge eco-system (and the only preferred investor for the University of Cambridge). Adam Glinsman holds a BSc (Econ.) with First Class Honours from the London School of Economics and an MPhil in International Relations from Cambridge University. He is based in Cambridge.
  • DR TOM HOWAT

    DR TOM HOWAT

    Chief Technology Officer

    Dr Tom Howat is Chief Technology Officer at Cantab Capital Partners, which became part of GAM Systematic in October 2016. He heads up the team of scientists responsible for Cantab’s ongoing infrastructure development. Much of the framework underpinning all of Cantab’s critically important functions has been designed by Tom Howat and his team. This includes the back-testing systems; trading and automated execution; real-time risk management and signal computation; trade allocations between different managed accounts etc. Prior to joining Cantab, Tom Howat spent seven years at Trinity College, Cambridge, where he obtained degrees in Mathematics and a PhD in Mathematical Biology.
  • DR MASSOUD MUSSAVIAN

    DR MASSOUD MUSSAVIAN

    Director of Research

    Dr Massoud Mussavian is Director of Research in GAM Systematic’s Cantab team, responsible for leading the research on equity trading strategies. He previously held the role of Senior Scientist at Cantab Capital Partners, which became part of GAM Systematic in October 2016. He has been instrumental in the development of trading strategies for cash equities and is continuously expanding the team’s trading and strategy universe. Massoud was previously Managing Director at Goldman Sachs in London. He built up the one-delta strategies group in Europe. He also headed up the research and technology department for the quantitative proprietary trading desk, working on both low and high frequency trading strategies in European equities. Prior to Goldman Sachs, Massoud Mussavian was an Assistant Professor of Finance at London Business School, where he taught equity investment management and PhD level courses in asset pricing. Massoud Mussavian has a PhD in Finance from New York University. He also holds a BSc in Mathematics from Imperial College London. He is based in Cambridge.
  • FRASER MCINTYRE

    FRASER MCINTYRE

    Chief Operating Officer

    Fraser McIntyre is Chief Operating Officer of GAM Systematic, overseeing all operational areas of the business, including finance, operations, legal and compliance. He was previously COO at Cantab Capital Partners, which became part of GAM Systematic in October 2016. He is a qualified Chartered Accountant with 15 years of experience in the hedge fund industry. Fraser McIntyre started his career in the Prime Broking divisions at Goldman Sachs and UBS, followed by a series of COO/CFO roles at single managers, including Meditor Capital Management in London. He joined Cantab in 2013. Fraser McIntyre holds a degree in Business Studies and Accounting from the University of Edinburgh.
  • NATALIE DAW

    NATALIE DAW

    Head of Business Development

    Natalie is responsible for the global systematic investor base and leads a team of product specialists. She was previously Head of Investor Relations of Cantab Capital Partners, which became part of GAM Systematic in October 2016. She has been working in the investment management industry for over 15 years, and has been specialising in systematic investment products for the past 7 years. Prior to joining Cantab in 2011 she worked at Phoenix Asset Management – a long only equities house and before that at Solent Capital Partners, a hedge fund manager specialising in credit investments. She started her career in asset management at TGM UK Ltd, a global macro manager based in London and Brisbane. She is based in Cambridge.
  • THE SCIENTISTS

    THE SCIENTISTS

    The heart of our business

    Over half of our employees are engaged in research and development – it is absolutely central to what we do.
    Cantab deliberately focuses on attracting top scientists from a wide variety of backgrounds, rather than primarily from other investment houses.  This broad range of experience has enabled us to think differently and as a result build portfolios with limited correlation to major systematic indices and to our biggest competitors in the space.
    Cantab's team combines a diverse skill set, with the common denominator being academic excellence and collegial team spirit.  We believe that a collaborative atmosphere and the spirit of team work are ingrained in Cantab’s psyche and underpin our investment philosophy.

Disclaimer

This website is issued in the United Kingdom by Cantab Capital Partners LLP ("CCP") which is regulated in the conduct of its investment business by the FCA.
Any investments or investment services mentioned in this website are not available to private customers. Any funds managed by CCP are not being marketed in EU or EEA jurisdictions other than any Approved AIFMD Jurisdiction (as defined below) and any EU or EEA investor other an Approved AIFMD Jurisdiction investor who wishes to obtain information on CCP funds will only be provided any such materials upon receipt by CCP of an appropriate reverse solicitation request in accordance with the requirements of the EU AIFM Directive and national law in their home jurisdiction.  The following is an "Approved AIFMD Jurisdiction" for the foregoing purposes: the United Kingdom, Sweden, Finland. The representative of the relevant Fund in Switzerland (the “Representative in Switzerland”) is Société Générale, Paris, Zurich Branch, Talacker 50, 8001 Zurich. The paying agent of the relevant Fund in Switzerland is Société Générale, Paris, Zurich Branch, Talacker 50, 8001 Zurich. In respect of the Shares distributed in Switzerland, the place of performance and jurisdiction is at the registered office of the Representative in Switzerland.

This financial promotion is issued by Cantab Capital Partners LLP which is authorised and regulated by the Financial Conduct Authority ("FCA"). The funds managed by CCP (the "Funds") are defined as "Unregulated Collective Investment Schemes" ("UCIS") and the promotion of a UCIS either within the UK or from the UK is severely restricted by statute. Consequently, this document is only made available to professional clients and eligible counterparties as defined by the FCA. Shares in the Funds should only be purchased by persons with professional experience of participating in unregulated schemes and any other person who receives this document should not rely upon it.
The distribution of the information contained in this website in certain countries may be restricted by law and persons who access it are required to inform themselves and to comply with any such restrictions. This information does not constitute an offer or solicitation in any jurisdiction. Prospective investors should inform themselves as to applicable legal requirements, exchange control regulations and taxes in the countries of their citizenship, residence or domicile.

This website is published solely for informational purposes and has no regard to the specific investment objectives, financial situation or particular needs of any person. Information contained herein is believed to be reliable but no warranty is given as to its accuracy or completeness and views and opinions, whilst given in good faith, are subject to change without notice.

The entire contents of the www.cantabcapital.com Internet site (the "site") are subject to copyright with all rights reserved. You may download or print individual sections of the site for your personal use and information only provided that you retain all copyright and other proprietary notices. You may not reproduce (in whole or in part), transmit (by electronic means or otherwise), modify, link into or use for any public or commercial purpose the site without the prior written permission of CCP. You must not transmit any virus or other item of a destructive nature to the site and it is your responsibility to ensure that whatever you download or select for your use from the site is free from such items.
Where an unauthorised link to a non-CCP website exists, CCP does not accept responsibility for the content of such site nor the products, services or other items offered through that site.
This website is established in England by CCP in accordance with and shall be governed by, and your browsing in and use of the site shall be deemed acceptance of, the laws of England and Wales. A condition of using the Site is that in the event of any dispute or proceeding you irrevocably submit to the exclusive jurisdiction of the English Courts and waive any objection to proceedings in such courts on the grounds of venue or on the grounds that the proceedings have been brought in an inconvenient forum.

Cantab - Part of GAM Systematic; City House, 126-130 Hills Road, Cambridge, CB2 1RE, UK
Registered in England No: OC317557
Thank you for visiting Cantab Capital Partners.